Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Traws Pharma (TRAW) Receivables - Other (2016 - 2019)

Historic Receivables - Other for Traws Pharma (TRAW) over the last 5 years, with Q2 2019 value amounting to $1.7 million.

  • Traws Pharma's Receivables - Other changed N/A to $1.7 million in Q2 2019 from the same period last year, while for Jun 2019 it was $1.7 million, marking a year-over-year change of. This contributed to the annual value of $35000.0 for FY2018, which is N/A changed from last year.
  • Traws Pharma's Receivables - Other amounted to $1.7 million in Q2 2019.
  • In the past 5 years, Traws Pharma's Receivables - Other registered a high of $2.1 million during Q2 2016, and its lowest value of $31000.0 during Q4 2016.
  • Moreover, its 4-year median value for Receivables - Other was $1.3 million (2015), whereas its average is $1.1 million.
  • Its Receivables - Other has fluctuated over the past 5 years, first surged by 94848.48% in 2015, then plummeted by 9776.01% in 2016.
  • Over the past 4 years, Traws Pharma's Receivables - Other (Quarter) stood at $1.4 million in 2015, then crashed by 97.76% to $31000.0 in 2016, then grew by 12.9% to $35000.0 in 2018, then soared by 4757.14% to $1.7 million in 2019.
  • Its Receivables - Other stands at $1.7 million for Q2 2019, versus $35000.0 for Q4 2018 and $31000.0 for Q4 2016.